Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
BPC-157, TB-500, CJC-1295/Ipamorelin, and PEG-MGF all fall under this restriction, with BPC-157 and CJC-1295/Ipamorelin having specifically appeared on the FDA's interim 503A bulk drug substances list
Because tumor growth also depends on new blood vessels, several reviews describe this as a theoretical concern that has not been resolved in humans (Sehgal et al., Pharmaceuticals, 2025)
However, these symptoms often subside over time as the body adjusts
BPC-157 may reduce pain and improve function by enhancing blood supply to the peripheral labrum and reducing associated inflammation
Given that you are applying this compound to your scalp repeatedly over months, source selection matters for both safety and efficacy
